Publication | Closed Access

Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection

VaccinationNanomedicineCross-protectionToxoplasma Gondii InfectionEngineeringMucosal VaccinationMedicineVaccine TargetImmunoengineeringImmunologyImmunodominanceTherapeutic VaccineVaccine DesignPolyvalent VaccineMulti-epitope PeptidePlga Nanoparticles